These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8736932

  • 1. Immunogold localization of adhalin, alpha-dystroglycan and laminin in normal and dystrophic skeletal muscle.
    Cullen MJ, Walsh J, Roberds SL, Campbell KP.
    Biochem Soc Trans; 1996 May; 24(2):274S. PubMed ID: 8736932
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Electron microscopic observations of triple immunogold labelling for dystrophin, beta-dystroglycan and adhalin in human skeletal myofibers.
    Inoue M, Wakayama Y, Murahashi M, Shibuya S, Jimi T, Kojima H, Oniki H.
    Acta Neuropathol; 1996 Dec; 92(6):569-75. PubMed ID: 8960314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Costameric distribution of beta-dystroglycan (43 kDa dystrophin-associated glycoprotein) in normal and dystrophin-deficient human skeletal muscle.
    Herrmann R, Anderson LV, Voit T.
    Biochem Soc Trans; 1996 May; 24(2):501-6. PubMed ID: 8736792
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Laminin-alpha2 (merosin), beta-dystroglycan, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study.
    ter Laak HJ, Leyten QH, Gabreëls FJ, Kuppen H, Renier WO, Sengers RC.
    Clin Neurol Neurosurg; 1998 Mar; 100(1):5-10. PubMed ID: 9637197
    [Abstract] [Full Text] [Related]

  • 14. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy.
    Ishii H, Hayashi YK, Nonaka I, Arahata K.
    Neuromuscul Disord; 1997 May; 7(3):191-7. PubMed ID: 9185184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
    Côté PD, Moukhles H, Lindenbaum M, Carbonetto S.
    Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laminin beta 2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy).
    Wewer UM, Durkin ME, Zhang X, Laursen H, Nielsen NH, Towfighi J, Engvall E, Albrechtsen R.
    Neurology; 1995 Nov; 45(11):2099-101. PubMed ID: 7501167
    [Abstract] [Full Text] [Related]

  • 19. Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane.
    Matsubara S, Mizuno Y, Kitaguchi T, Isozaki E, Miyamoto K, Hirai S.
    Neuromuscul Disord; 1999 Oct; 9(6-7):388-98. PubMed ID: 10545042
    [Abstract] [Full Text] [Related]

  • 20. Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation.
    Yamamoto T, Shibata N, Kanazawa M, Kobayashi M, Komori T, Ikeya K, Kondo E, Saito K, Osawa M.
    Acta Neuropathol; 1997 Aug; 94(2):173-9. PubMed ID: 9255393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.